AstraZeneca’s ($AZN) breast cancer drug Enhertu has been granted Breakthrough Therapy Designation by the U.S. Food and Drug ...

Get the live share price of AstraZeneca PLC ADR (AZN), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.

British drugmaker AstraZeneca (AZN), fresh off a record-high stock price, continues to draw interest from U.S. and European investors thanks to, among others, its plan to start trading directly in New ...

For anyone wondering whether AstraZeneca is still worth considering after its big run or whether the best days are already priced in, this article will walk through what the numbers are really saying ...

AstraZeneca AZN stock has risen 15% so far this year compared with an increase of 0.2% for the industry. The stock has also outperformed the sector and the S&P 500 index, as seen in the chart below.

AstraZeneca's shares jumped after Pfizer's announcement of a major deal with the Trump administration. Pfizer's good news could benefit AstraZeneca, too. Pfizer CEO Albert Bourla appeared with ...

The FDA has concluded that Andexxa's risk profile is no longer favorable. AstraZeneca will stop sales of Andexxa in US.

Shares of AstraZeneca (NASDAQ: AZN) have jumped more than 10% this week. On Monday, the British drugmaker reported positive results from a clinical study of Enhertu in treating HER2-positive early ...